Responsible AI
in Clinical Trials
in Clinical Trials
Stay informed with AI industry insiders! Pre-register for the 3rd virtual summit in 2025.
Returning and New Powerhouses 2024
Building on last year's success, leading voices from top organizations have confirmed their participation as speakers for this year's summit. Don't miss their valuable insights.
From Bots to Trusted Agents:
Ensuring Validity in AI for Clinical Trials
Ensuring Validity in AI for Clinical Trials
AI in clinical trials is advancing from basic tools to sophisticated agents, making validation and reliability more crucial than ever. This summit will gather expertise to address concerns about AI accuracy, particularly in Decision Support Systems and Predictive Modeling, and explore effective, responsible integration into clinical trials through real-world applications and emerging trends.
We are proud to introduce a diverse range of speakers for the 2024 summit:
Linda Sullivan
Senior Fellow
at Tufts Center for the Study
of Drug Development
at Tufts Center for the Study
of Drug Development
Dr Andrzej Kinasiewicz
Director,
Centralized Monitoring
at Astra Zeneca
Centralized Monitoring
at Astra Zeneca
Wole Moses
Chief AI Officer
at Microsoft
Federal Civilian
at Microsoft
Federal Civilian
Dr Mariana Hebborn
Global Head of HR AI
& Data Governance
at Merck
& Data Governance
at Merck
Danny Goh
Founder & CEO
at Nexus FrontierTech,
co-author The AI Republic
at Nexus FrontierTech,
co-author The AI Republic
Jessica Cordes
Senior Consultant
and Trainer
at Clinical Excellence
and Trainer
at Clinical Excellence
Nechama Katan
Director Innovative
Data Analytics
at Pfizer
Data Analytics
at Pfizer
Dr Mary Jo Lamberti
Research Associate Professor and
Director of Sponsored Research
at Tufts CSDD
Director of Sponsored Research
at Tufts CSDD
Sigrid Berge
van Rooijen
van Rooijen
AI Business Consultant
at Eir Health
at Eir Health
Ron Burns
Subject Matter Expert
in AI for Clinical Trials,
Biofourmis
in AI for Clinical Trials,
Biofourmis
Kanchana Iyer
Sr Consultant,
Regulatory Affairs
at Halloran
Regulatory Affairs
at Halloran
Meghan Patterson
Associate
Principal Consultant
at Halloran
Principal Consultant
at Halloran
Patrick Risch
Partner Risk Consulting
Digitalization & Technology
at EY
Digitalization & Technology
at EY
Nurcan Coskun
Former Global Head
of RBQM
at Medtronic
of RBQM
at Medtronic
Dr Lakkavalli Amrith
AI Master
Tech Advocate
at Fortrea
Tech Advocate
at Fortrea
Artem Andrianov, PhD
Chief Executive Officer
& Founder
at Cyntegrity
& Founder
at Cyntegrity
Event Details
Dates
October 8 & 9, 2024
Time
15:00 - 17:30 CEST | 9:00 AM - 11:30 AM EDT
Format
Virtual, 2 webinars of 2.5 hours each
Virtual Summit Program 2024
Spreading over two days with sessions lasting 2.5 hours each, this free event aims to foster meaningful dialogue on Responsible AI in clinical trials.
DAY 1 | TUESDAY, OCTOBER 8
- Introduction & Welcome Remarks - Event objectives & the importance of AI in clinical trials
- AI as an Assistant - What are the practical applications of AI as an assistant, and how can it be supervised effectively to ensure accurate and reliable outcomes?
- Bias and Fairness - AI is only as unbiased as its data. How can we identify and mitigate biases in AI algorithms used in clinical trials, and what steps can be taken to ensure these models are fair and unbiased?
- Building Trust and Driving Adoption (Stakeholder and Panel Discussion) - Strategies for integrating validated AI into clinical trials: Explore how to build trust, manage change, and engage stakeholders in adopting AI technologies that are reliable and validated.
- Q/A & Closing Remarks
DAY 2 | WEDNESDAY, OCTOBER 9
- Recap Day 1 - Insights & Observations
- Real-World Applications of Trusted AI - What are some successful case studies of validated AI implementation in clinical trials, and what lessons can be learned from these to guide future AI projects?
- Navigating AI Legislation - We will examine the latest regulatory updates and guidelines for AI in clinical trials and how organizations can ensure compliance while maintaining the validity and trustworthiness of AI-augmented systems.
- Future Trends (Stakeholder and Panel Discussion) - What are the emerging trends in AI technology that could impact clinical trials, and how can organizations stay ahead of the curve and prepare for future AI advancements?
- Q/A & Closing Remarks - Summary & next steps for Responsible AI
Who Should Join the Dialogue?
Directors and Senior Managers specializing in: Clinical Operations & Study Management, Innovation & New Technologies, Clinical Monitoring & Site Management, Project & Program Management
Heads of Therapeutic Areas and Medical Affairs
Functional Leads in Data Management and Biostatistics
Compliance and Quality Assurance Officers
Regulatory Affairs Executives
We're on the verge of a new era in clinical trials, where AI processes data and understands human emotions and preferences.
Let's leverage AI's power to create a future where technology and humanity collaborate to improve healthcare outcomes.
Artem Andrianov, PhD
CEO & Founder of Cyntegrity
Got 10 Minutes?
How do you see the future of AI in clinical trials? Help us understand the impact of AI in clinical trials.
AI-Augmented RBQM Solutions
©2024 Cyntegrity - All Rights Reserved
